These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21516670)

  • 21. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
    Maggioni AP; Fabbri G; Lucci D; Marchioli R; Franzosi MG; Latini R; Nicolosi GL; Porcu M; Cosmi F; Stefanelli S; Tognoni G; Tavazzi L;
    Eur Heart J; 2009 Oct; 30(19):2327-36. PubMed ID: 19717850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats.
    Zeghichi-Hamri S; de Lorgeril M; Salen P; Chibane M; de Leiris J; Boucher F; Laporte F
    Nutr Res; 2010 Dec; 30(12):849-57. PubMed ID: 21147368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques.
    Calder PC; Yaqoob P
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):28-37. PubMed ID: 20196967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of omega-3 fatty acids from fish in prevention of cardiovascular diseases].
    Reiner E; Tedeschi-Reiner E; Stajminger G
    Lijec Vjesn; 2007; 129(10-11):350-5. PubMed ID: 18257336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secondary prevention of coronary artery disease with omega-3 fatty acids.
    Jacobson TA
    Am J Cardiol; 2006 Aug; 98(4A):61i-70i. PubMed ID: 16919518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Marfisi RM; Nicolosi GL; Tavazzi L; Tognoni G; Valagussa F;
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):347-50. PubMed ID: 16645413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. n-3 Fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators.
    Christensen JH; Riahi S; Schmidt EB; Mølgaard H; Kirstein Pedersen A; Heath F; Cosedis Nielsen J; Toft E
    Europace; 2005 Jul; 7(4):338-44. PubMed ID: 15944091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance.
    Sakamoto A; Saotome M; Iguchi K; Maekawa Y
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly purified omega-3 polyunsaturated fatty acids in clinical development.
    Vik H
    Herz; 2006 Dec; 31 Suppl 3():83-95. PubMed ID: 17575810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-3 fatty acids and cardiac autonomic function in humans.
    Christensen JH; Svensson M; Strandhave C; Madsen T; Schmidt EB
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):131-9. PubMed ID: 20196976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel developments in omega-3 fatty acid-based strategies.
    Davidson MH; Kling D; Maki KC
    Curr Opin Lipidol; 2011 Dec; 22(6):437-44. PubMed ID: 21986642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-chain omega-3 fatty acids from fish reduce sudden cardiac death in patients with coronary heart disease.
    Richter WO
    Eur J Med Res; 2003 Aug; 8(8):332-6. PubMed ID: 12915328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mediterranean diet and n-3 fatty acids in the prevention and treatment of cardiovascular disease.
    de Lorgeril M; Salen P
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S38-41. PubMed ID: 17876197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic effects of omega-3 fatty acids.
    Reiffel JA; McDonald A
    Am J Cardiol; 2006 Aug; 98(4A):50i-60i. PubMed ID: 16919517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
    Tavazzi L; Tognoni G; Franzosi MG; Latini R; Maggioni AP; Marchioli R; Nicolosi GL; Porcu M;
    Eur J Heart Fail; 2004 Aug; 6(5):635-41. PubMed ID: 15302013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
    Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. n-3 PUFAs and heart failure.
    Marchioli R; Levantesi G
    Int J Cardiol; 2013 Dec; 170(2 Suppl 1):S28-32. PubMed ID: 24012159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease.
    Harper CR; Jacobson TA
    Am J Cardiol; 2005 Dec; 96(11):1521-9. PubMed ID: 16310434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of drugs and devices in patients at risk of sudden cardiac death.
    Boriani G; Diemberger I; Valzania C; Biffi M; Martignani C; Raschi E; Mantovani V; Ziacchi M; Bertini M; De Ponti F; Branzi A
    Fundam Clin Pharmacol; 2010 Oct; 24(5):575-94. PubMed ID: 20608989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antiarrhythmia effects of omega-3 fatty acids. A review].
    De Caterina R; Madonna R
    Ital Heart J Suppl; 2002 Mar; 3(3):297-308. PubMed ID: 12040845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.